-4 Risk stratification plays a crucial role in guiding treatment decisions and has traditionally relied on prostate-specific antigen (PSA) levels, Gleason score, tumor stage, and the percentage of positive biopsy cores.5 This evidence concerns the gene KLK3 and neoplasm.